Transarterial hepatic chemoperfusion of uveal melanoma metastases: Survival and response to treatment

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 183, Issue 12, 2011, Pages 1151-1160

  Heusner, T A ^a   Antoch, G ^b   Wittkowski Sterczewski, A ^a   Ladd, S C ^a   Forsting, M ^a   Verhagen, R ^a   Scheulen, M ^c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Institut für Diagnostische und Interventionelle Radiologie   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

angiography; chemoperfusion; interventional procedures; melphalan; ocular melanoma; uveal melanoma

Indexed keywords

DACARBAZINE; DOXORUBICIN; FOTEMUSTINE; GRANISETRON; IOPROMIDE; MELPHALAN; MITOMYCIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LEUKOPENIA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT RESPONSE; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE PROGRESSION; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER FAILURE; LIVER NEOPLASMS; MALE; MELANOMA; MELPHALAN; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UVEAL NEOPLASMS;

EID: 82955195843     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0031-1281743     Document Type: Article

References (38)

1. Virgili G, Gatta G, Ciccolallo L et al. Incidence of uveal melanoma in Europe. Ophthalmology 2007 114 2309-2315
2. Egan K M., Seddon J M., Glynn R J. et al. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 1988 32 239-251 (Pubitemid 18066234)
3. Eskelin S, Pyrhonen S, Summanen P et al. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology 2000 107 1443-1449
4. Bedikian A Y., Legha S S., Mavligit G et al. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer 1995 76 1665-1670
5. Herman P, Machado M A., Montagnini A L. et al. Selected patients with metastatic melanoma may benefit from liver resection. World J Surg 2007 31 171-174 (Pubitemid 46089562)
6. Gragoudas E S., Egan K M., Seddon J M. et al. Survival of patients with metastases from uveal melanoma. Ophthalmology 1991 98 383-389; discussion 390
7. Kath R, Hayungs J, Bornfeld N et al. Prognosis and treatment of disseminated uveal melanoma. Cancer 1993 72 2219-2223 (Pubitemid 23280150)
8. Rajpal S, Moore R, Karakousis C P. Survival in metastatic ocular melanoma. Cancer 1983 52 334-336 (Pubitemid 13063179)
9. Peters S, Voelter V, Zografos L et al. Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients. Ann Oncol 2006 17 578-583
10. Lane A M., Egan K M., Harmon D et al. Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis. Ophthalmology 2009 116 2206-2212
11. Sato T, Eschelman D J., Gonsalves C F. et al. Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor. JClin Oncol 2008 26 5436-5442
12. Yamamoto A, Chervoneva I, Sullivan K L. et al. High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanoma. Radiology 2009 252 290-298
13. Mavligit G M., Charnsangavej C, Carrasco C H. et al. Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. Jama 1988 260 974-976
14. Bates D A., Mackillop W J. The effect of hyperthermia in combination with melphalan on drug-sensitive and drug-resistant CHO cells in vitro. Br J Cancer 1990 62 183-188 (Pubitemid 20242432)
15. Zee J van der, Kroon B B., Nieweg O E. et al. Rationale for different approaches to combined melphalan and hyperthermia in regional isolated perfusion. Eur J Cancer 1997 33 1546-1550 (Pubitemid 28123473)
16. Hafstrom L R., Holmberg S B., Naredi P L. et al. Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy. Surg Oncol 1994 3 103-108 (Pubitemid 24237137)
17. Rothbarth J, Pijl M E., Vahrmeijer A L. et al. Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver. Br J Surg 2003 90 1391-1397 (Pubitemid 37421675)
18. Vahrmeijer A L., Dierendonck J H., Keizer H J. et al. Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver. Br J Cancer 2000 82 1539-1546 (Pubitemid 30204359)
19. Voelter V van, Schalenbourg A, Pampallona S et al. Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients. Melanoma Res 2008 18 220-224 (Pubitemid 351684668)
20. Egerer G, Lehnert T, Max R et al. Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients. Int J Clin Oncol 2001 6 25-28 (Pubitemid 32230359)
21. Fety R, Lucas C, Solere P et al. Hepatic intra-arterial infusion of fotemustine: pharmacokinetics. Cancer Chemother Pharmacol 1992 31 118-122
22. Etten B van, Wilt J H., Brunstein F de et al. Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases. Eur J Surg Oncol 2009 35 539-545
23. Alexander H R., Libutti S K., Pingpank J F. et al. Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver. Clin Cancer Res 2003 9 6343-6349 (Pubitemid 38031818)
24. Iersel L B., Hoekman E J., Gelderblom H van et al. Isolated hepatic perfusion with 200mg melphalan for advanced noncolorectal liver metastases. Ann Surg Oncol 2008 15 1891-1898
25. Noter S L., Rothbarth J Jr, Pijl M E. et al. Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver. Melanoma Res 2004 14 67-72 (Pubitemid 38392417)
26. Leoni C J., Potter J E., Rosen M P. et al. Classifying complications of interventional procedures: a survey of practicing radiologists. JVasc Interv Radiol 2001 12 55-59 (Pubitemid 32095676)
27. Rivoire M, Kodjikian L, Baldo S et al. Treatment of liver metastases from uveal melanoma. Ann Surg Oncol 2005 12 422-428 (Pubitemid 40884256)
28. Leyvraz S, Spataro V, Bauer J et al. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. JClin Oncol 1997 15 2589-2595 (Pubitemid 27289889)
29. Becker J C., Terheyden P, Kampgen E et al. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2. Br J Cancer 2002 87 840-845 (Pubitemid 35252958)
30. Albert M L., Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998 392 86-89 (Pubitemid 28150594)
31. Bowen D G., McCaughan G W., Bertolino P. Intrahepatic immunity: a tale of two sites? Trends Immunol 2005 26 512-517 (Pubitemid 41297680)
32. Fiorentini G, Aliberti C, Del Conte A et al. Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study. In Vivo 2009 23 131-137
33. Vogl T, Eichler K, Zangos S et al. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival. JCancer Res Clin Oncol 2007 133 177-184 (Pubitemid 46144093)
34. Osuga K, Hori S, Hiraishi K et al. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres. Cardiovasc Intervent Radiol 2008 31 1108-1116
35. Gonsalves C F., Eschelman D J., Sullivan K L. et al. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience. Am J Roentgenol 2011 196 468-473
36. Antoch G, Mueller S P., Hamami M et al. Selective internal radiotherapy (SIRT) for hepatocellular carcinoma. Fortschr Röntgenstr 2010 182 660-670
37. Hamami M E., Poeppel T D., Muller S et al. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer. JNucl Med 2009 50 688-692
38. Heusner T A., Hamami M E., Ertle J et al. Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization. Fortschr Röntgenstr 2010 182 603-608